Drug Pipeline

QLC5508 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
2
Recruiting
2
Phase 3
1
Top Sponsors
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-06-08 NCT07632690 QLC5508 in Participants With Metastatic Prostate Cancer Phase 3 Not Yet Recruiting
2026-06-02 NCT07620041 QLC5508 in Advanced Solid Tumors:: C-QTc, Pharmacokinetics (PK) Comparisons and Drug-drug… Phase 1 Not Yet Recruiting
Active Studies by Phase
Phase 3
2
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07463573 QLC5508 vs. Chemotherapy in Pretreated Advanced or Metastatic Esophageal Squamous Cell… Esophageal Squamous Cell Carcinoma (ESCC) Recruiting
NCT07632690 QLC5508 in Participants With Metastatic Prostate Cancer Prostate Cancer Not Yet Recruiting
Phase 1/2
NCT07198633 A Clinical Study of QLC5508 and/or QLH12016 in Combination With Other Anti-tumor… Advanced Prostate Cancer Recruiting
Phase 1
NCT07620041 QLC5508 in Advanced Solid Tumors:: C-QTc, Pharmacokinetics (PK) Comparisons and Drug-drug… Refractory or Relapsed Solid Tumors Not Yet Recruiting
Sponsors Running QLC5508 Trials
Disease Areas
Get alerts when QLC5508 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free